[Levels of proteolytic enzymes in experimental osteoarthrosis controlled by antirheumatic agents].
D000818:Animals; D001842:Bone and Bones / Q000201:enzymology; D002358:Cartilage, Articular / Q000201:enzymology; D020789:Cathepsin C; D002402:Cathepsin D / Q000378:metabolism*; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / Q000378:metabolism*; D005260:Female; D006854:Hydrocortisone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy / Q000201:enzymology*; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011817:Rabbits
C100280:kebuzone; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D020789:Cathepsin C; D002402:Cathepsin D; D010653:Phenylbutazone; C007133:hydrocortisone hemisuccinate; D006854:Hydrocortisone
Hladiny proteolytických enzymů pri experimentální osteoartróze ovlivnĕné antirevmatiky.